Icon Group completed the acquisition of Pharmaxo Group.

Icon Group, a cancer care provider, completed the acquisition of Pharmaxo Group, a pharmaceutical specialist manufacturer and clinical homecare provider. Financial terms were not disclosed. “Welcoming Pharmaxo to Icon Group reflects our ongoing commitment to improving access to world-class healthcare in the UK,” Mark Middleton, Icon Group CEO.